271
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and safety profile of calcineurin inhibitor salvage therapy in autoimmune hepatitis

, , , , , , , , , , , , & show all
Pages 1309-1317 | Received 30 Jun 2020, Accepted 01 Sep 2020, Published online: 17 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Cumali Efe. (2021) Tacrolimus as second-line therapy in acute severe autoimmune hepatitis. Scandinavian Journal of Gastroenterology 56:3, pages 298-298.
Read now

Articles from other publishers (4)

Pinelopi Arvaniti, Ignasi Olivas, Sergio Rodriguez-Tajes, George N. Dalekos & Maria-Carlota Londoño. (2024) Second- and third-line treatment agents in autoimmune hepatitis (AIH): Where do we stand?. Exploration of Digestive Diseases, pages 92-106.
Crossref
Irina Adao, Arielle Klepper & Michele Tana. (2024) AIH Therapy: Beyond First-Line. Current Hepatology Reports.
Crossref
Dan Luo, Haodang Luo, Xiaoliang Yan, Aihua Lei, Jun He, Yating Liao, Kailan Peng, Xia Li, Youyuan Ye, Li Chen, Zhuo Zeng, Hua Xiao & Yanhua Zeng. (2023) Mycoplasma genitalium Protein of Adhesion Suppresses T Cell Activation via CypA-CaN-NFAT Pathway. Microbiology Spectrum 11:3.
Crossref
Diego Vergani, Benedetta Terziroli Beretta-Piccoli & Giorgina Mieli-Vergani. (2021) A reasoned approach to the treatment of autoimmune hepatitis. Digestive and Liver Disease 53:11, pages 1381-1393.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.